StockGuild
Long

$IDXG On The Run Again and this time it will be sustained

NASDAQ:IDXG   INTERPACE BIOSCIENCES INC
Let's recap $IDXG CC:

1. New York State and AETNA approvals of ThyraMIR®, microRNA assay

2. Talked about the Debt being restructured

3. No more offerings

4. Reduced operating costs

5. Talks of doing business with their BarreGen model

6. Talks of partnering with another bio he didn't discuss.

7. EPS value of $3.25 vs -($12.04) same quarter last year

8. Sales of $3.122 million.

9. Goldman, Rodman and Renshaw, Barclays were on the CC too big boys will be here soon enough count on it.

10. 64% of the S/S is SHORT

11. Raised $14 million in gross equity and restructured over $9.3 million of secured debt

12. Revenue increased 39%

Also most importantly the Patent Approval!!!

$IDXG European Patent Decision https://data.epo.org/publication-server/...

ALSO FULL YEAR HIGHLIGHTS READ HERE: http://ih.advfn.com/p.php?pid=nmona&%...
Comment: Alerted this on Twitter earlier in the day. Will post charts in real time next time.

Comments

Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features Pricing Refer a friend House Rules Help Center Website & Broker Solutions Widgets Charting Solutions Lightweight Charting Library Blog & News Twitter
Profile Profile Settings Account and Billing Refer a friend My Support Tickets Help Center Ideas Published Followers Following Private Messages Chat Sign Out